Interactive Extreme: Scale Analytics Towards Battling Cancer

N. Giatrakos et al. - IEEE Technology and Society Magazine - vol. 38, no. 2, pp. 54-61, June 2019.

Abstract

A synergetic understanding of cancer evolution and the effect of combination drug therapies on the disease is the cornerstone for developing effective personalized treatments, which can radically improve patients’ well-being and their quality of (work and social) life. By extension, improving the treatment of patients indirectly enhances the quality of life for families, friends, and careers. Moreover, personalizing effective therapeutic approaches reduces treatment duration, cutting down healthcare monetary costs, which can be redirected to other health and social services. Given that three out of four U.S. families will at some point experience a family member suffering from cancer (http://natamcancer.org/NAP_Native_American_Priorities.pdf), the potential impact of improved cancer treatment is of considerable socio-economic and organizational significance.

Go to publication:

This project has received funding from the European Union Horizon 2020 research and innovation programme under grant agreement No 825070.

Let's get in touch!